A Risk Prediction Index for Amiodarone-Induced Thyrotoxicosis in Adults with Congenital Heart Disease
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Amiodarone therapy in adults with congenital heart disease (CHD) is associated with a significant risk of amiodarone-induced thyrotoxicosis (AIT). We developed a risk index to identify those patients being considered for amiodarone treatment who are at high risk for AIT. We reviewed the health records of adults with CHD and assessed the association between potential clinical predictors and AIT. Significant predictors were included in multivariate analyses. The parameter estimates from multivariate analysis were subsequently used to develop a risk index. 169 adults met eligibility criteria and 23 developed AIT. The final model included age, cyanotic heart disease and BMI. The risk index developed identified 3 categories of risk. Their AIT likelihood ratios were: 0.37 for low risk (95% CI 0.15–0.92); 1.12 for medium risk (95% CI 0.65–1.91); and 3.47 for high risk (95% CI 1.7–7.11). The AIT predicted risk in our population was 5% for the low risk group, 15% for the medium risk group and 47% for the high risk group.Conclusions. We derived the first model to quantify the risk for developing AIT among adults with CHD. Before using it clinically to help selecting among alternative antiarrhythmic options, it needs validation in an independent population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laupacis, A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540300056034 · Cited by 793
Methodologic Standards for the Development of Clinical Decision Rules in Emergency Medicine
STIELL, I., & WELLS, G. (1999) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(99)70309-4 · Cited by 571 · cited 1×
“In order to construct the instrument, we opted for Cox proportional hazard analysis as opposed to recursive partitioning given our aim for high overall accuracy where both low and high risk for AIT are important outcomes in our cohort [22].”
MethodAtrial Arrhythmias in Adults With Congenital Heart Disease
Bouchardy, J., Therrien, J., Pilote, L., Ionescu-Ittu, R., Martucci, G., Bottega, N., & Marelli, A. J. (2009) · Circulation · doi:10.1161/circulationaha.109.866319 · Cited by 476 · cited 1×
“individuals experience tachyarrhythmias, mainly atrial, at > 20% prevalence with more than double the risk of adverse events (stroke, heart failure) compared to those without arrhythmia [3].”
BackgroundAmiodarone-Induced Thyrotoxicosis
Daniels, G. H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7119 · Cited by 159
Eskes, S. A., & Wiersinga, W. M. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.07.001 · Cited by 148
Studies on the in vitro cytotoxic effect of amiodarone.
Chiovato, L., Martino, E., Tonacchera, M., Santini, F., Lapi, P., Mammoli, C., Braverman, L. E., & Pinchera, A. (1994) · Endocrinology · doi:10.1210/endo.134.5.8156930 · Cited by 107 · cited 1×
“The explanation for this novel association likely relates to the preferential deposition of amiodarone in adipose tissue combined with its concentration-dependent cytotoxicity [17, 18] and the current clinical practice of giving a fixed, rather than a weight-adjusted, dose of amiodarone.”
BackgroundBRENNAN, M. D., ERICKSON, D. Z., CARNEY, J. A., & BAHN, R. S. (1995) · Thyroid · doi:10.1089/thy.1995.5.177 · Cited by 61 · cited 1×
“The explanation for this novel association likely relates to the preferential deposition of amiodarone in adipose tissue combined with its concentration-dependent cytotoxicity [17, 18] and the current clinical practice of giving a fixed, rather than a weight-adjusted, dose of amiodarone.”
BackgroundSelf-citationAdaptation of Human CD4+ T Cells to Pathophysiological Hypoxia: A Transcriptome Analysis
GABER, T., HÄUPL, T., SANDIG, G., TYKWINSKA, K., FANGRADT, M., TSCHIRSCHMANN, M., HAHNE, M., DZIURLA, R., EREKUL, K., LAUTENBACH, M., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090255 · Cited by 47 · cited 1×
“These consistencies along with its biological plausibility [12] led us to include cyanosis in the final model.”
Background
Cited by
Khairy, P., Van Hare, G. F., Balaji, S., Berul, C. I., Cecchin, F., Cohen, M. I., Daniels, C. J., Deal, B. J., Dearani, J. A., Groot, N. D., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.05.009 · Cited by 709
Self-citationPage, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000311 · Cited by 595
“heart disease, inducible AF, and increased LA size (121, 312-316).”
Background2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.856 · Cited by 439
Hernández-Madrid, A., Paul, T., Abrams, D., Aziz, P. F., Blom, N. A., Chen, J., Chessa, M., Combes, N., Dagres, N., Diller, G., et al. (2018) · EP Europace · doi:10.1093/europace/eux380 · Cited by 317
2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes III, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2015.09.019 · Cited by 206
Metadata
- Authors
- Stan, M. N., Hess, E. P., Bahn, R. S., Warnes, C. A., Ammash, N. M., Brennan, M. D., Thapa, P., & Montori, V. M.
- Venue
- Journal of Thyroid Research
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-7
- ISSN
- 2042-0072 (ISSN-L)
- 2090-8067
- OpenAlex
- W1991047815
- Cited by
- 21
- References
- 8
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.